Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 307 entries
Sorted by: Best Match Show Resources per page
Classification of acoustical signals by combining active learning strategies with semi-supervised learning schemes

Asset based approaches STEM training

Aridas C, Kanas VG, Karlos S, Kotsiantis S.
GSID: V4EGxx1e-WkJ
S Karlos, C Aridas, VG Kanas, S Kotsiantis - Neural Computing and …, 2021 - Springer

… a combinatory approach over three problems, which stem from … , which operates under training sets with small cardinality, … its assets and defects, but without Single-view methods are the …

Cite
Karlos, S., Aridas, C., Kanas, V. G., & Kotsiantis, S. (2021). Classification of acoustical signals by combining active learning strategies with semi-supervised learning schemes. Neural Computing and Applications, 1-18.
Karlos, Stamatis, et al. "Classification of acoustical signals by combining active learning strategies with semi-supervised learning schemes." Neural Computing and Applications (2021): 1-18.
Copy Download .nbib Format: MLA
Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

The journal of pathology. Clinical research

Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M.
PMID: 27499890
J Pathol Clin Res. 2014 Dec 04;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan.

Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large-scale analyses are limited by the need for high throughput, standardized scoring methods. To...

Cite
Howat WJ, Blows FM, Provenzano E, et al. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2014;1(1):18-32doi: 10.1002/cjp2.3.
Howat, W. J., Blows, F. M., Provenzano, E., Brook, M. N., Morris, L., Gazinska, P., Johnson, N., McDuffus, L. A., Miller, J., Sawyer, E. J., Pinder, S., van Deurzen, C. H., Jones, L., Sironen, R., Visscher, D., Caldas, C., Daley, F., Coulson, P., Broeks, A., Sanders, J., Wesseling, J., Nevanlinna, H., Fagerholm, R., Blomqvist, C., Heikkilä, P., Ali, H. R., Dawson, S. J., Figueroa, J., Lissowska, J., Brinton, L., Mannermaa, A., Kataja, V., Kosma, V. M., Cox, A., Brock, I. W., Cross, S. S., Reed, M. W., Couch, F. J., Olson, J. E., Devillee, P., Mesker, W. E., Seyaneve, C. M., Hollestelle, A., Benitez, J., Perez, J. I., Menéndez, P., Bolla, M. K., Easton, D. F., Schmidt, M. K., Pharoah, P. D., Sherman, M. E., & García-Closas, M. (2015). Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. The journal of pathology. Clinical research, 1(1), 18-32. https://doi.org/10.1002/cjp2.3
Howat, William J, et al. "Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium." The journal of pathology. Clinical research vol. 1,1 (2015): 18-32. doi: https://doi.org/10.1002/cjp2.3
Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. J Pathol Clin Res. 2014 Dec 04;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan. PMID: 27499890; PMCID: PMC4858117.
Copy Download .nbib Format: NLM
Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia.

World journal of clinical cases

Poulin MF, Shah A, Trohman RG, Madias C.
PMID: 26090373
World J Clin Cases. 2015 Jun 16;3(6):519-24. doi: 10.12998/wjcc.v3.i6.519.

A 54-year-old female with Anderson-Fabry disease (AFD)-R342Q missense mutation on exon 7 in alpha-galactosidase A (GLA) gene - presented with sustained ventricular tachycardia. Imaging confirmed the presence of a new left ventricular apical aneurysm (LVAA) and a significantly reduced...

Cite
Poulin MF, Shah A, Trohman RG, et al. Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia. World J Clin Cases. 2015;3(6):519-24doi: 10.12998/wjcc.v3.i6.519.
Poulin, M. F., Shah, A., Trohman, R. G., & Madias, C. (2015). Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia. World journal of clinical cases, 3(6), 519-24. https://doi.org/10.12998/wjcc.v3.i6.519
Poulin, Marie-France, et al. "Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia." World journal of clinical cases vol. 3,6 (2015): 519-24. doi: https://doi.org/10.12998/wjcc.v3.i6.519
Poulin MF, Shah A, Trohman RG, Madias C. Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia. World J Clin Cases. 2015 Jun 16;3(6):519-24. doi: 10.12998/wjcc.v3.i6.519. PMID: 26090373; PMCID: PMC4468899.
Copy Download .nbib Format: NLM
Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy.

Case reports in oncology

Musa F, Baidas S.
PMID: 26034479
Case Rep Oncol. 2015 Apr 22;8(1):196-9. doi: 10.1159/000381868. eCollection 2015.

We here describe a patient with an idiopathic thrombotic thrombocytopenic purpura (TTP) secondary to an ADAMTS13 inhibitor that continued to be dependent on plasmapheresis until the patient was treated with rituximab. TTP manifestations subsided with rituximab treatment in spite...

Cite
Musa F, Baidas S. Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy. Case Rep Oncol. 2015;8(1):196-9doi: 10.1159/000381868.
Musa, F., & Baidas, S. (2015). Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy. Case reports in oncology, 8(1), 196-9. https://doi.org/10.1159/000381868
Musa, Faisal, and Baidas, Said. "Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy." Case reports in oncology vol. 8,1 (2015): 196-9. doi: https://doi.org/10.1159/000381868
Musa F, Baidas S. Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy. Case Rep Oncol. 2015 Apr 22;8(1):196-9. doi: 10.1159/000381868. eCollection 2015. PMID: 26034479; PMCID: PMC4448046.
Copy Download .nbib Format: NLM
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.

Breast cancer research : BCR

Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, Lenburg ME, Korkola JE, Bayani N, Samarajiwa S, Seoane JA, Dane MA, Esch A, Feiler HS, Wang NJ, Hardwicke MA, Laquerre S, Jackson J, Wood KW, Weber B, Spellman PT, Aparicio S, Wooster R, Caldas C, Gray JW.
PMID: 28183333
Breast Cancer Res. 2017 Feb 09;19(1):17. doi: 10.1186/s13058-017-0809-6.

No abstract available.

Cite
Hu Z, Mao JH, Curtis C, et al. Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Res. 2017;19(1):17doi: 10.1186/s13058-017-0809-6.
Hu, Z., Mao, J. H., Curtis, C., Huang, G., Gu, S., Heiser, L., Lenburg, M. E., Korkola, J. E., Bayani, N., Samarajiwa, S., Seoane, J. A., Dane, M. A., Esch, A., Feiler, H. S., Wang, N. J., Hardwicke, M. A., Laquerre, S., Jackson, J., Wood, K. W., Weber, B., Spellman, P. T., Aparicio, S., Wooster, R., Caldas, C., & Gray, J. W. (2017). Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast cancer research : BCR, 19(1), 17. https://doi.org/10.1186/s13058-017-0809-6
Hu, Zhi, et al. "Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer." Breast cancer research : BCR vol. 19,1 (2017): 17. doi: https://doi.org/10.1186/s13058-017-0809-6
Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, Lenburg ME, Korkola JE, Bayani N, Samarajiwa S, Seoane JA, Dane MA, Esch A, Feiler HS, Wang NJ, Hardwicke MA, Laquerre S, Jackson J, Wood KW, Weber B, Spellman PT, Aparicio S, Wooster R, Caldas C, Gray JW. Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Res. 2017 Feb 09;19(1):17. doi: 10.1186/s13058-017-0809-6. PMID: 28183333; PMCID: PMC5301377.
Copy Download .nbib Format: NLM
Vsx1 Transiently Defines an Early Intermediate V2 Interneuron Precursor Compartment in the Mouse Developing Spinal Cord.

Frontiers in molecular neuroscience

Francius C, Hidalgo-Figueroa M, Debrulle S, Pelosi B, Rucchin V, Ronellenfitch K, Panayiotou E, Makrides N, Misra K, Harris A, Hassani H, Schakman O, Parras C, Xiang M, Malas S, Chow RL, Clotman F.
PMID: 28082864
Front Mol Neurosci. 2016 Dec 26;9:145. doi: 10.3389/fnmol.2016.00145. eCollection 2016.

Spinal ventral interneurons regulate the activity of motor neurons, thereby controlling motor activities. Interneurons arise during embryonic development from distinct progenitor domains distributed orderly along the dorso-ventral axis of the neural tube. A single ventral progenitor population named p2...

Cite
Francius C, Hidalgo-Figueroa M, Debrulle S, et al. Vsx1 Transiently Defines an Early Intermediate V2 Interneuron Precursor Compartment in the Mouse Developing Spinal Cord. Front Mol Neurosci. 2016;9:145doi: 10.3389/fnmol.2016.00145.
Francius, C., Hidalgo-Figueroa, M., Debrulle, S., Pelosi, B., Rucchin, V., Ronellenfitch, K., Panayiotou, E., Makrides, N., Misra, K., Harris, A., Hassani, H., Schakman, O., Parras, C., Xiang, M., Malas, S., Chow, R. L., & Clotman, F. (2016). Vsx1 Transiently Defines an Early Intermediate V2 Interneuron Precursor Compartment in the Mouse Developing Spinal Cord. Frontiers in molecular neuroscience, 9145. https://doi.org/10.3389/fnmol.2016.00145
Francius, Cédric, et al. "Vsx1 Transiently Defines an Early Intermediate V2 Interneuron Precursor Compartment in the Mouse Developing Spinal Cord." Frontiers in molecular neuroscience vol. 9 (2016): 145. doi: https://doi.org/10.3389/fnmol.2016.00145
Francius C, Hidalgo-Figueroa M, Debrulle S, Pelosi B, Rucchin V, Ronellenfitch K, Panayiotou E, Makrides N, Misra K, Harris A, Hassani H, Schakman O, Parras C, Xiang M, Malas S, Chow RL, Clotman F. Vsx1 Transiently Defines an Early Intermediate V2 Interneuron Precursor Compartment in the Mouse Developing Spinal Cord. Front Mol Neurosci. 2016 Dec 26;9:145. doi: 10.3389/fnmol.2016.00145. eCollection 2016. PMID: 28082864; PMCID: PMC5183629.
Copy Download .nbib Format: NLM
Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals.

Molecular therapy. Methods & clinical development

Pridans C, Lillico S, Whitelaw B, Hume DA.
PMID: 26015955
Mol Ther Methods Clin Dev. 2014 Apr 09;1:14010. doi: 10.1038/mtm.2014.10. eCollection 2014.

The development of macrophages requires signaling through the lineage-restricted receptor Csf1r. Macrophage-restricted expression of transgenic reporters based upon Csf1r requires the highly conserved Fms-intronic regulatory element (FIRE). We have created a lentiviral construct containing mouse FIRE and promoter. The...

Cite
Pridans C, Lillico S, Whitelaw B, et al. Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals. Mol Ther Methods Clin Dev. 2014;1:14010doi: 10.1038/mtm.2014.10.
Pridans, C., Lillico, S., Whitelaw, B., & Hume, D. A. (2014). Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals. Molecular therapy. Methods & clinical development, 114010. https://doi.org/10.1038/mtm.2014.10
Pridans, Clare, et al. "Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals." Molecular therapy. Methods & clinical development vol. 1 (2014): 14010. doi: https://doi.org/10.1038/mtm.2014.10
Pridans C, Lillico S, Whitelaw B, Hume DA. Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals. Mol Ther Methods Clin Dev. 2014 Apr 09;1:14010. doi: 10.1038/mtm.2014.10. eCollection 2014. PMID: 26015955; PMCID: PMC4362345.
Copy Download .nbib Format: NLM
Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists.

International journal of women's health

James AH, Cooper DL, Paidas MJ.
PMID: 26604829
Int J Womens Health. 2015 Nov 04;7:873-81. doi: 10.2147/IJWH.S89573. eCollection 2015.

OBJECTIVE: To assess potential diagnostic and practice barriers to successful management of massive postpartum hemorrhage (PPH), emphasizing recognition and management of contributing coagulation disorders.STUDY DESIGN: A quantitative survey was conducted to assess practice patterns of US obstetrician-gynecologists in managing...

Cite
James AH, Cooper DL, Paidas MJ. Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists. Int J Womens Health. 2015;7:873-81doi: 10.2147/IJWH.S89573.
James, A. H., Cooper, D. L., & Paidas, M. J. (2015). Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists. International journal of women's health, 7873-81. https://doi.org/10.2147/IJWH.S89573
James, Andra H, et al. "Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists." International journal of women's health vol. 7 (2015): 873-81. doi: https://doi.org/10.2147/IJWH.S89573
James AH, Cooper DL, Paidas MJ. Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists. Int J Womens Health. 2015 Nov 04;7:873-81. doi: 10.2147/IJWH.S89573. eCollection 2015. PMID: 26604829; PMCID: PMC4639551.
Copy Download .nbib Format: NLM
Response to: Ticagrelor recommended over clopidogrel, only in clinical trials or also in a real-world practice?.

Expert review of cardiovascular therapy

Pappas C, Lekakis J, Alexopoulos D.
PMID: 27546190
Expert Rev Cardiovasc Ther. 2016 Oct;14(10):1105. doi: 10.1080/14779072.2016.1222903. Epub 2016 Aug 22.

No abstract available.

Cite
Pappas C, Lekakis J, Alexopoulos D. Response to: Ticagrelor recommended over clopidogrel, only in clinical trials or also in a real-world practice?. Expert Rev Cardiovasc Ther. 2016;14(10):1105doi: 10.1080/14779072.2016.1222903.
Pappas, C., Lekakis, J., & Alexopoulos, D. (2016). Response to: Ticagrelor recommended over clopidogrel, only in clinical trials or also in a real-world practice?. Expert review of cardiovascular therapy, 14(10), 1105. https://doi.org/10.1080/14779072.2016.1222903
Pappas, Christos, et al. "Response to: Ticagrelor recommended over clopidogrel, only in clinical trials or also in a real-world practice?." Expert review of cardiovascular therapy vol. 14,10 (2016): 1105. doi: https://doi.org/10.1080/14779072.2016.1222903
Pappas C, Lekakis J, Alexopoulos D. Response to: Ticagrelor recommended over clopidogrel, only in clinical trials or also in a real-world practice?. Expert Rev Cardiovasc Ther. 2016 Oct;14(10):1105. doi: 10.1080/14779072.2016.1222903. Epub 2016 Aug 22. PMID: 27546190.
Copy Download .nbib Format: NLM
Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study.

Cardiovascular radiation medicine

Ahmed JM, Waksman R, Weissman NJ, Harrington D, Pappas C, Hong MK, Satler LF, Caños D, Kent KM, Pichard AD, Mintz GS.
PMID: 11068279
Cardiovasc Radiat Med. 2001 Jan 01;2(1):58.

No abstract available.

Cite
Ahmed JM, Waksman R, Weissman NJ, et al. Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study. Cardiovasc Radiat Med. 2001;2(1):58
Ahmed, J. M., Waksman, R., Weissman, N. J., Harrington, D., Pappas, C., Hong, M. K., Satler, L. F., Caños, D., Kent, K. M., Pichard, A. D., & Mintz, G. S. (2001). Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study. Cardiovascular radiation medicine, 2(1), 58.
Ahmed, et al. "Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study." Cardiovascular radiation medicine vol. 2,1 (2001): 58.
Ahmed JM, Waksman R, Weissman NJ, Harrington D, Pappas C, Hong MK, Satler LF, Caños D, Kent KM, Pichard AD, Mintz GS. Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study. Cardiovasc Radiat Med. 2001 Jan 01;2(1):58. PMID: 11068279.
Copy Download .nbib Format: NLM
An ethnic predilection for fetal echogenic intracardiac focus identified during targeted midtrimester ultrasound examination: A retrospective review.

BMC pregnancy and childbirth

Rebarber A, Levey KA, Funai E, Monda S, Paidas M.
PMID: 15219230
BMC Pregnancy Childbirth. 2004 Jun 25;4(1):12. doi: 10.1186/1471-2393-4-12.

BACKGROUND: Echogenic intracardiac focus (EIF) has been identified as a common ultrasound finding in association with fetal aneuploidy. Little is known about the association of this soft marker aneuploidy in various ethnic groups. Although it is commonly thought Asians...

Cite
Rebarber A, Levey KA, Funai E, et al. An ethnic predilection for fetal echogenic intracardiac focus identified during targeted midtrimester ultrasound examination: A retrospective review. BMC Pregnancy Childbirth. 2004;4(1):12doi: 10.1186/1471-2393-4-12.
Rebarber, A., Levey, K. A., Funai, E., Monda, S., & Paidas, M. (2004). An ethnic predilection for fetal echogenic intracardiac focus identified during targeted midtrimester ultrasound examination: A retrospective review. BMC pregnancy and childbirth, 4(1), 12. https://doi.org/10.1186/1471-2393-4-12
Rebarber, Andrei, et al. "An ethnic predilection for fetal echogenic intracardiac focus identified during targeted midtrimester ultrasound examination: A retrospective review." BMC pregnancy and childbirth vol. 4,1 (2004): 12. doi: https://doi.org/10.1186/1471-2393-4-12
Rebarber A, Levey KA, Funai E, Monda S, Paidas M. An ethnic predilection for fetal echogenic intracardiac focus identified during targeted midtrimester ultrasound examination: A retrospective review. BMC Pregnancy Childbirth. 2004 Jun 25;4(1):12. doi: 10.1186/1471-2393-4-12. PMID: 15219230; PMCID: PMC449713.
Copy Download .nbib Format: NLM
A role for INDEPTH Asian sites in translating research to action for non-communicable disease prevention and control: a case study from Ballabgarh, India.

Global health action

Krishnan A, Nongkynrih B, Kapoor SK, Pandav C.
PMID: 20027258
Glob Health Action. 2009 Sep 28;2. doi: 10.3402/gha.v2i0.1990.

BACKGROUND: The International Network of field sites with continuous Demographic Evaluation of Populations and Their Health (INDEPTH) has 34 Health and Demographic Surveillance System (HDSS) in 17 different low and middle-income countries. Of these, 23 sites are in Africa,...

Cite
Krishnan A, Nongkynrih B, Kapoor SK, et al. A role for INDEPTH Asian sites in translating research to action for non-communicable disease prevention and control: a case study from Ballabgarh, India. Glob Health Action. 2009;2doi: 10.3402/gha.v2i0.1990.
Krishnan, A., Nongkynrih, B., Kapoor, S. K., & Pandav, C. (2009). A role for INDEPTH Asian sites in translating research to action for non-communicable disease prevention and control: a case study from Ballabgarh, India. Global health action, 2. https://doi.org/10.3402/gha.v2i0.1990
Krishnan, Anand, et al. "A role for INDEPTH Asian sites in translating research to action for non-communicable disease prevention and control: a case study from Ballabgarh, India." Global health action vol. 2 (2009). doi: https://doi.org/10.3402/gha.v2i0.1990
Krishnan A, Nongkynrih B, Kapoor SK, Pandav C. A role for INDEPTH Asian sites in translating research to action for non-communicable disease prevention and control: a case study from Ballabgarh, India. Glob Health Action. 2009 Sep 28;2. doi: 10.3402/gha.v2i0.1990. PMID: 20027258; PMCID: PMC2785101.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 307 entries